1st Circ. Ends Takeda FCA Suit But Limits Scope Of Ruling
The First Circuit on Friday tossed a whistleblower's closely watched False Claims Act suit accusing Takeda Pharmaceutical Co. Ltd. of defrauding Medicare by concealing drug risks, finding insufficient specifics but declining...To view the full article, register now.
Already a subscriber? Click here to view full article